Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers L > Headlines for Lorus Therapeutics Inc. > News item |
Technifund reports 12.8% stake in Lorus Therapeutics
By Lisa Kerner
Charlotte, N.C., Feb. 4 - Lorus Therapeutics Inc. investors led by Technifund Inc. and Herbert Abramson bought 2,519,000 shares of the company's stock for a total ownership interest of 13.8%.
The shares were purchased between Dec. 12 and Feb. 1 priced from $0.17 to $0.19 each, according to a schedule 13D filing with the Securities and Exchange Commission.
The investors beneficially own 29,788,904 shares of the Toronto-based biopharmaceutical company's outstanding stock.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.